Improving the quality of life in Arizona to benefit future generations.
Building Arizona as a global center for research and commercialization in the biosciences.
Connect with Flinn Bioscience: Stay up to date. Join our email list.
The Flinn Foundation supports the biosciences in Arizona through research and entrepreneurship grants as well as stewardship of Arizona’s Bioscience Roadmap, guiding the growth and development of the state’s bioscience sector. A third iteration of the Roadmap will be released in fall 2025.
The Roadmap’s tagline, “Advancing the Biosciences and Improving Health Outcomes” recognizes the broad spectrum of the biosciences, including research, academia, and product commercialization, as well as the central role of health care within the bioscience sector.
The biosciences improve our world by developing treatments for health afflictions with safer and more affordable medicines, creating diagnostics that gauge and prevent illness, and strengthening our food supply. In addition, the biosciences strengthen and diversify our economy by creating cutting-edge companies and high-paying jobs.
Heather Carter, Blue Cross Blue Shield of Arizona Health Choice CEO and chair of the Arizona’s Bioscience Roadmap Steering Committee, will share new data from TEConomy Partners highlighting Arizona bioscience and hospital jobs, wages, federal grants, venture capital, university tech-transfer, and other measures.
There will also be a discussion about academic research opportunities and challenges during these tumultuous times and a report from SRI International about what to expect from the new Roadmap coming in September.
The Zoom webinar will be held from noon to 1:30 p.m. on Wednesday, April 23. This will be the final data report under the current iteration of the Roadmap. [Register]
Arizona bioscience companies Anuncia Medical and Macula Vision Systems have been selected from a competitive field of startups to receive funding support through the 2025 Flinn Foundation Bioscience Entrepreneurship Program.
The companies receive $100,000 in non-dilutive funding support through the Arizona Bioindustry Association, the Foundation’s nonprofit partner. The 2025 program’s 10 participants — including eight companies not selected for funding — were announced March 6 at the Flinn Foundation Bio Capital Conference at the Creighton University Health Sciences Campus in Phoenix.
Now in its 12th cohort, the entrepreneurship program was established to support Arizona’s Bioscience Roadmap goal of creating a thriving hub for bioscience entrepreneurs and startups across the state. [Read more]
The March 6 Flinn Foundation Bio Capital Conference, “Managing Growth and VC Capital As You Scale,” brought together bioscience founders, investors, ecosystem partners, and service providers at the Creighton University Health Sciences Campus in Phoenix for a day of learning and networking.
Attendees at the sold-out event learned about who is funding the biosciences, talked with venture capitalists and local CEOs, and heard from keynote speaker Michael Gorton, founder of Teladoc. [Learn more]
Courtney Williams, CEO of Tucson-based Emagine Solutions Technology, co-founded the company to improve maternal health outcomes.
As a mother diagnosed with postpartum preeclampsia just days after giving birth to her first child—and seeing family members suffer their own maternal health crises—Williams has a personal motivation as well. After living through her health scare, Williams decided to create The Journey app for pregnant women to track vitals in real time and receive immediate feedback if numbers are out of range.
Emagine Solutions Technology was also a 2019 participant in the Flinn Foundation Bioscience Entrepreneurship Program. [Read more]
The Flinn Foundation Seed Grants to Promote Translational Research program has awarded a combined $1 million to 10 Arizona research teams with the potential to turn their findings into viable products and treatments that impact patients.
Seven of the selected projects are being led by the University of Arizona and three by Arizona State University. The Arizona-based researchers are developing medical devices, diagnostics, therapeutics, and technology to treat a number of conditions. In addition, three projects that received their initial grant in 2023 qualified for $100,000 each in follow-on funding over the next year. [Learn more]
Bioscience
Heather Carter, Blue Cross Blue Shield of Arizona Health Choice CEO and chair of the Arizona’s Bioscience Roadmap Steering Committee, will share new data from TEConomy Partners highlighting Arizona bioscience and hospital jobs, wages, federal grants, venture capital, university tech-transfer, and other measures. The Zoom webinar will be held from noon to 1:30 p.m. on […]
Bioscience
Mayo Clinic to invest nearly $2 billion in Valley hospital campus, hire thousands / Phoenix Business Journal
Mayo Clinic plans to invest $1.9 billion and add 3,500 more jobs to its north Phoenix campus, adjacent to the Discovery Oasis biotech innovation hub, adding 1.2 million square feet of space by 2031.
Bioscience
Arizona bioscience companies Anuncia Medical and Macula Vision Systems have been selected from a competitive field of startups to receive funding support through the 2025 Flinn Foundation Bioscience Entrepreneurship Program. The companies receive $100,000 in non-dilutive funding support through the Arizona Bioindustry Association, the Foundation’s nonprofit partner. In addition, they can access professional and consulting […]
Bioscience
The March 6 Flinn Foundation Bio Capital Conference, “Managing Growth and VC Capital As You Scale,” brought together bioscience founders, investors, ecosystem partners, and service providers at the Creighton University Health Sciences Campus in Phoenix for a day of learning and networking. Attendees at the sold-out event learned about who is funding the biosciences, […]